Preventive treatments in elderly people needs rethinkingAugust 10, 2007Rather than prolonging life, preventive treatments in elderly people may simply change the cause of death - the manner of our dying, say doctors in this week's BMJ. They call for a more sophisticated way of assessing the benefits and harms of preventive treatment in elderly people. Preventive health care aims to delay the onset of illness and disease and to prevent untimely and premature deaths, say Dr Dee Mangin and colleagues. But concerns about equity of access to treatments have led to preventive interventions being encouraged regardless of age, and this can be harmful to the patient and expensive for the health service.
In rapidly ageing populations, we urgently need to reappraise the complex and uncomfortable relations between age discrimination, distributive justice, quality, and length of life, they argue. For example, preventive use of statins shows no overall benefit in elderly people as cardiovascular mortality and morbidity are replaced by cancer. Is it possible, they ask, that by introducing preventive treatments in the elderly aimed at reducing the risk of a particular cause of death, we are simply changing the cause of death without the patient's informed consent" This is fundamentally unethical, undermining the principle of respect for autonomy. Financial incentives for doctors that are linked to guidelines and targets may coerce doctors into persuading patients to accept such preventive treatments, they add, but the best interests of elderly people might lie in investing the money in health care that will genuinely relieve suffering, such as cataract operations, joint replacement surgery, and personal care of people with dementia. They believe that a more sophisticated model is needed to assess preventive treatment in the elderly that takes a wider perspective when balancing potential harms against putative benefits. We should not carry on extrapolating data from younger populations and using linear models that use absolute risks of disease rather than all cause mortality and morbidity. If we do, the only ones to benefit will be drug companies, with increasing profits from an ageing population consumed by epidemics rather than enjoying their long life, they conclude. BMJ-British Medical Journal | |||||||||||||||||||||
|
Related Preventive Treatment Current Events and Preventive Treatment News Articles Redesigned protein accelerates blood clotting Researchers have made several, subtle changes in the structure of a key protein, dramatically increasing its ability to drive blood clotting, according to a study published in a December edition of the Journal of Thrombosis and Haemostasis. Research highlights new approaches to prevent blood clots Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Dramatic fall in malaria in the Gambia raises possibility of elimination in parts of Africa The incidence of malaria has fallen significantly in The Gambia in the last 5 years, according to a study carried out by experts there with support from scientists based in London. Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately The gender gap is alive and well in heart disease, a new international study finds, with women differing from men on everything from symptoms to treatment in both heart attack and severe chest pain. International health experts to enlist the public in war on African malaria Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute. National Jewish Medical and Research Center Evaluating Treatment To Prevent Allergic Reactions to Food Researchers at National Jewish Medical and Research Center are conducting trials to evaluate a method to prevent allergic reactions to food. They are feeding peanut- and egg-allergic people increasing doses of an investigational protein extract from the foods to see if they can induce the participants' immune systems to tolerate the food. Gene variation may elevate risk of liver tumor in patients with cirrhosis A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause of cancer death. First-Ever Study: Lack of Critical Lubricant Causes Wear in Joints Mice that don't produce lubricin, a thin film of protein found in the cartilage of joints, showed early wear and higher friction in their joints, a new study led by Brown University researchers shows. Mice with a migraine show signs of brain damage Migraines may be doing more than causing people skull-splitting pain. Scientists have found evidence that the headaches may also be acting like tiny transient strokes, leaving parts of the brain starved for oxygen and altering the brain in significant ways. Early onset of poor bone mineralization revealed in children with cystic fibrosis In a study of children with cystic fibrosis, French researchers found evidence of very early onset defective bone mineralization in the lumbar spine that was not caused by either nutritional status or lung disease. More Preventive Treatment Current Events and Preventive Treatment News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||